CD79A and vibrio infectious disease: Importantly, after 2 oral doses of the WC-BS prototype vaccine the intestinal IgA anti-CTB and anti-LPS responses were fully comparable to those induced naturally in concurrently examined Bangladeshi convalescents from severe clinical cholera [15].